As of 2025-05-17, the Fair Value of Aridis Pharmaceuticals Inc (ARDS) is -397.28 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.31 USD, the upside of Aridis Pharmaceuticals Inc is -128,212.87%.
With the market price of 0.31 USD and our fair value calculation, Aridis Pharmaceuticals Inc (ARDS) is not a good investment. Investing in ARDS stocks now will result in a potential loss of 128,212.87%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -22.11 | -29.68 | -22.33 | -42.19 | -30.37 | -29.34 |
| YoY growth | 10.34% | -34.24% | 24.76% | -88.94% | 28.01% | -12.01% |
| Market Cap (mil) | 0.00 |
| P/E | |
| Forward P/E |
| EPS | -79.46 |
| Avg earnings growth rate | -12.01% |
| TTM earnings | -1.14 |